GB201411907D0 - Targeted imaging agent - Google Patents

Targeted imaging agent

Info

Publication number
GB201411907D0
GB201411907D0 GBGB1411907.7A GB201411907A GB201411907D0 GB 201411907 D0 GB201411907 D0 GB 201411907D0 GB 201411907 A GB201411907 A GB 201411907A GB 201411907 D0 GB201411907 D0 GB 201411907D0
Authority
GB
United Kingdom
Prior art keywords
imaging agent
targeted imaging
targeted
agent
imaging
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1411907.7A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kings College London
Original Assignee
Kings College London
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kings College London filed Critical Kings College London
Priority to GBGB1411907.7A priority Critical patent/GB201411907D0/en
Publication of GB201411907D0 publication Critical patent/GB201411907D0/en
Priority to PCT/GB2015/051931 priority patent/WO2016001671A1/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/085—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier conjugated systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10—Organic compounds
    • A61K49/14—Peptides, e.g. proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/088—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins conjugates with carriers being peptides, polyamino acids or proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/53—Colony-stimulating factor [CSF]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5091—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing the pathological state of an organism
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/50—Determining the risk of developing a disease
GBGB1411907.7A 2014-07-03 2014-07-03 Targeted imaging agent Ceased GB201411907D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB1411907.7A GB201411907D0 (en) 2014-07-03 2014-07-03 Targeted imaging agent
PCT/GB2015/051931 WO2016001671A1 (en) 2014-07-03 2015-07-01 Peptide imaging agent targeted to the extracellular portion of cd115

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1411907.7A GB201411907D0 (en) 2014-07-03 2014-07-03 Targeted imaging agent

Publications (1)

Publication Number Publication Date
GB201411907D0 true GB201411907D0 (en) 2014-08-20

Family

ID=51410607

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1411907.7A Ceased GB201411907D0 (en) 2014-07-03 2014-07-03 Targeted imaging agent

Country Status (2)

Country Link
GB (1) GB201411907D0 (en)
WO (1) WO2016001671A1 (en)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060239913A1 (en) 2003-06-25 2006-10-26 Marc Port Peptide conjugate for magnetic resonance imaging
US20080193376A1 (en) * 2004-10-28 2008-08-14 The General Hospital Corporation Methods of Enhanced Detection and Therapy of Inflamed Tissues Using Immune Modulation
GB201102189D0 (en) * 2011-02-08 2011-03-23 King S College London Materials and methods relating to cardiovascular imaging

Also Published As

Publication number Publication date
WO2016001671A1 (en) 2016-01-07

Similar Documents

Publication Publication Date Title
IL250685A0 (en) Cytotoxicity-inducing therapeutic agent
GB2530831B (en) Targeted mutations
HK1258690A1 (en) Food-improving agent
IL255931B (en) Imaging device
GB201413109D0 (en) Endoscopic imaging
SG11201608284XA (en) Medical imaging
GB2528102B (en) Ophthalmoscopes
GB201419261D0 (en) Formulations
GB201419091D0 (en) Formulations
SG10201404895XA (en) Diagnosis
IL249075A0 (en) Fluoroalkylating agent
GB201407339D0 (en) Monitor
HK1226296A1 (en) Retinoic-acid-producing agent
IL250160A0 (en) Pharmaceutical agent
GB2531721B (en) Imaging Device
GB201406616D0 (en) Imaging
EP3171776C0 (en) Imaging arrangement
GB201412199D0 (en) Imaging system
GB201410983D0 (en) Quick hitch
GB201411907D0 (en) Targeted imaging agent
PL3290048T3 (en) Immunity-inducing agent
GB201517277D0 (en) Imaging device
GB2521504B (en) An attachment means
GB201509077D0 (en) Imaging device
GB201509073D0 (en) Imaging device

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)